Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 132.67M P/E - EPS this Y 77.10% Ern Qtrly Grth -
Income -80.85M Forward P/E -1.15 EPS next Y -163.00% 50D Avg Chg 3.00%
Sales 95.84M PEG -0.68 EPS past 5Y - 200D Avg Chg -56.00%
Dividend N/A Price/Book N/A EPS next 5Y 5.20% 52W High Chg -91.00%
Recommedations 2.00 Quick Ratio 7.93 Shares Outstanding 226.23M 52W Low Chg 53.00%
Insider Own 2.95% ROA -15.63% Shares Float 187.64M Beta 1.96
Inst Own 81.12% ROE -863.39% Shares Shorted/Prior 8.55M/9.58M Price 1.39
Gross Margin 100.00% Profit Margin -84.36% Avg. Volume 2,536,038 Target Price 6.72
Oper. Margin 54.35% Earnings Date Nov 7 Volume 1,718,679 Change 0.00%
About Gossamer Bio, Inc.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Gossamer Bio, Inc. News
12:00 PM All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy
11/15/24 After Plunging -20% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
11/14/24 After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
11/12/24 Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts
11/11/24 Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/10/24 Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets
11/07/24 Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates
11/07/24 Gossamer Bio: Q3 Earnings Snapshot
11/07/24 Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
10/31/24 NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule
10/30/24 Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now
10/29/24 Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now
10/28/24 3 US Penny Stocks With Market Caps Under $900M To Consider
10/03/24 Several Insiders Invested In Gossamer Bio Flagging Positive News
09/25/24 Presenting on the Emerging Growth Conference 75 Day 2 on September 26
08/26/24 Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024
06:00 AM Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now
05:19 AM Analysts Just Made A Notable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Forecasts
08/16/24 With 73% institutional ownership, Gossamer Bio, Inc. (NASDAQ:GOSS) is a favorite amongst the big guns
08/12/24 Gossamer Bio (GOSS) Q2 Earnings and Revenues Lag Estimates
GOSS Chatroom

User Image Zlab_Investor Posted - 9 minutes from now

$GOSS 0 a distinct possibility over longer time frame; .25 sooner than you may think.

User Image PeasantToRich Posted - 1 minute from now

$GOSS Merck you shorting?

User Image SarlaccButtplug Posted - 3 hours ago

@mwb1 naw. $GOSS is the one.

User Image KING_OF_BIO Posted - 5 hours ago

$BCAB and $GOSS have been disappointing lately. What's the problem?!

User Image JJBurch Posted - 6 hours ago

$GOSS $BCTX It’s all about these two today and for the next 12 months $XBI $LLY Congratulations to all. It’s our time now.

User Image PeasantToRich Posted - 6 hours ago

$GOSS 👀

User Image Zlab_Investor Posted - 10 hours ago

$GOSS

User Image SarlaccButtplug Posted - 22 hours ago

$GOSS So all the upside price action is AH. No fuckery there. No Sirrie.

User Image nastento Posted - 1 day ago

$GOSS there's 0😂😂 besides cough

User Image Zlab_Investor Posted - 1 day ago

$GOSS

User Image Wisenheimer Posted - 1 day ago

$GOSS too many adverse events?

User Image BioRich Posted - 1 day ago

$GOSS what happened here?!?

User Image Jabed206 Posted - 1 day ago

$GOSS main factors towards down trend?

User Image x404 Posted - 1 day ago

$GOSS I am boned for a while

User Image BlewItAll Posted - 2 days ago

$GOSS I smell a hard reversal at some point.

User Image DanChevreuxx Posted - 2 days ago

$GOSS how many shares you guys have?

User Image wwmeinc Posted - 2 days ago

$GOSS ....Across a wide lists of name...Millennium Mgmt(Englander) has sold last qtr....as the list shows...maybe he is a buyer again now though as the filing rules sure gives these hedgies a bit of secrecy....glta https://whalewisdom.com/filer/millennium-management-l-l-c

User Image Zlab_Investor Posted - 2 days ago

$GOSS Fidelity dumping??

User Image PeasantToRich Posted - 2 days ago

$GOSS $156m market cap. That’s a joke.. have twice the amount of cash on hand

User Image nastento Posted - 2 days ago

$GOSS https://ir.gossamerbio.com/static-files/f85d23dd-c332-492d-b6a6-70735e33bb5c

User Image DanChevreuxx Posted - 2 days ago

$GOSS why do you guys like GOSS. Considering a big purchase and want to hear some opinions

User Image PeasantToRich Posted - 3 days ago

$GOSS

User Image PeasantToRich Posted - 3 days ago

$GOSS hold https://finance.yahoo.com/news/plunging-20-4-weeks-heres-143506767.html

User Image KING_OF_BIO Posted - 3 days ago

$GOSS Not looking good here for us...

User Image Zlab_Investor Posted - 3 days ago

$GOSS Wait for 0, or at least .25

User Image StockBoiChris Posted - 4 days ago

$GOSS Merck already has the market covered

User Image Zlab_Investor Posted - 6 days ago

$GOSS Remains an excellent super long term short in my opinion

User Image PeasantToRich Posted - 6 days ago

$GOSS we are trading at $170m market cap… Our pipeline has rival to winrevair. Merck is well-suited to commercialize Winrevair as it has had a PH drug on the market for a decade in Adempas, which it shares with Bayer. Analysts have estimated Winrevair's peak sales potential is at least $2 billion, with J.P. Morgan’s Chris Schott estimating it at $3 billion to $4 billion.

User Image PeasantToRich Posted - 6 days ago

$GOSS $GDRX good days to add at these levels

User Image PenkeTrading Posted - 6 days ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Gossamer Bio Inc. Is that bullish or bearish? $GOSS #RsiOversold #NASDAQ

Analyst Ratings
HC Wainwright & Co. Buy Sep 17, 24
HC Wainwright & Co. Buy Aug 30, 24
Wedbush Outperform Aug 13, 24
Oppenheimer Outperform Jun 25, 24
Goldman Sachs Buy Jun 17, 24
HC Wainwright & Co. Buy May 20, 24
Wedbush Outperform May 8, 24
HC Wainwright & Co. Buy May 6, 24
Piper Sandler Overweight Mar 27, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Giraudo Bryan COO/CFO COO/CFO Nov 13 Buy 0.5644 200,000 112,880 380,010 11/14/23
Christian Waage EVP, Tech Ops and Ad.. EVP, Tech Ops and Admin Mar 20 Buy 1.197 18,500 22,144 32,388 03/22/23
Giraudo Bryan COO/CFO COO/CFO Mar 20 Buy 0.9687 50,000 48,435 70,990 03/22/23
Hasnain Faheem President & CEO President & CEO Mar 20 Buy 1.12 878,572 984,001 4,495,897 03/22/23
Carter Laura Chief Scientific Off.. Chief Scientific Officer Mar 16 Sell 1.098 6,029 6,620 76,263 03/20/23
Aranda Richard Chief Medical Office.. Chief Medical Officer Mar 16 Sell 1.098 7,563 8,304 199,388 03/20/23
Peterson Caryn EVP, Regulatory Affa.. EVP, Regulatory Affairs Mar 16 Sell 1.098 7,564 8,305 53,851 03/20/23
Giraudo Bryan COO/CFO COO/CFO Jul 15 Buy 7.21 13,869 99,995 20,990 07/15/22
Hasnain Faheem President & CEO President & CEO Jul 15 Buy 7.21 138,696 999,998 3,617,325 07/15/22
Aranda Richard Chief Medical Office.. Chief Medical Officer Jun 22 Sell 6.88 1,778 12,233 209,897 06/23/22
Carter Laura Chief Scientific Off.. Chief Scientific Officer May 04 Sell 7.20 1,262 9,086 89,042 05/05/22
Christian Waage EVP, Tech Ops and Ad.. EVP, Tech Ops and Admin Mar 23 Sell 8.915 10,722 95,587 579,008 03/24/22
Hasnain Faheem President & CEO President & CEO Mar 23 Sell 8.915 19,035 169,697 143,465 03/24/22
Giraudo Bryan COO/CFO COO/CFO Mar 23 Sell 8.915 10,722 95,587 99,167 03/24/22
Carter Laura Chief Scientific Off.. Chief Scientific Officer Mar 16 Sell 8.278 5,002 41,407 90,304 03/17/22